Why is Avidity Biosciences (RNA) a Battleground Stock with Massive Short Interest

Related Articles

Why is Intellia Therapeutics (NTLA) a Battleground Stock with 38% Short Interest

7 months ago

What Does High Short Interest Really Mean for a Stock

7 months ago

Why is CleanSpark Attracting Such High Short Interest

8 months ago

Why is Kaixin Holdings (KXIN) Facing Such Extreme Short Interest

7 months ago

Category

You may also like

Stock News•1 months ago

Solid Biosciences: A Funded Challenge To Duchenne Gene Therapy's Limitations

Solid Biosciences is positioned as a speculative buy with a cash runway into mid-2028, funding its differentiated SGT-003 gene therapy for Duchenne muscular dystrophy. The thesis hinges on generating ...

SLDB

Share

Stock News•1 months ago

Is the Market Right or Wrong About These 4 High Short Interest Stocks?

High short interest stocks are drawing attention as a gauge of concentrated Wall Street skepticism, though the snippet provides no specific names, figures, or directional change.

COIN

Share

Stock News•3 months ago

Avidity Biosciences (NASDAQ:RNA) Stock Price Crosses Below 200-Day Moving Average – Here’s Why

Avidity Biosciences (RNA) fell ~60% below its 200-day moving average of $30.39, trading at $12.29 after hitting an intraday low of $11.61.

RNA

Share